ID   TOP1M_HUMAN             Reviewed;         601 AA.
AC   Q969P6; B7ZAR5; E7ES89; Q86ST4; Q86V82;
DT   31-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-JUN-2023, entry version 187.
DE   RecName: Full=DNA topoisomerase I, mitochondrial;
DE            Short=TOP1mt;
DE            EC=5.6.2.1 {ECO:0000255|PROSITE-ProRule:PRU10130};
DE   Flags: Precursor;
GN   Name=TOP1MT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), FUNCTION, COFACTOR,
RP   SUBCELLULAR LOCATION, TRANSIT PEPTIDE CLEAVAGE SITE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11526219; DOI=10.1073/pnas.191321998;
RA   Zhang H., Barcelo J.M., Lee B., Kohlhagen G., Zimonjic D.B., Popescu N.C.,
RA   Pommier Y.;
RT   "Human mitochondrial topoisomerase I.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:10608-10613(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT TRP-525.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ILE-256.
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Releases the supercoiling and torsional tension of DNA
CC       introduced during duplication of mitochondrial DNA by transiently
CC       cleaving and rejoining one strand of the DNA duplex. Introduces a
CC       single-strand break via transesterification at a target site in duplex
CC       DNA. The scissile phosphodiester is attacked by the catalytic tyrosine
CC       of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-
CC       enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free
CC       DNA strand then rotates around the intact phosphodiester bond on the
CC       opposing strand, thus removing DNA supercoils. Finally, in the
CC       religation step, the DNA 5'-OH attacks the covalent intermediate to
CC       expel the active-site tyrosine and restore the DNA phosphodiester
CC       backbone (By similarity). {ECO:0000250, ECO:0000269|PubMed:11526219}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP-independent breakage of single-stranded DNA, followed by
CC         passage and rejoining.; EC=5.6.2.1; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10130};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:11526219};
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:11526219};
CC       Note=Divalent metal ions (calcium or magnesium).
CC       {ECO:0000269|PubMed:11526219};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11526219}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q969P6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q969P6-2; Sequence=VSP_044783;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; highest in skeletal muscle, heart,
CC       brain and fetal liver. {ECO:0000269|PubMed:11526219}.
CC   -!- SIMILARITY: Belongs to the type IB topoisomerase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH44646.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF349031; AAL10791.1; -; Genomic_DNA.
DR   EMBL; AF349018; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349019; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349020; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349021; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349022; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349023; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349024; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349025; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349026; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349027; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349028; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349029; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349030; AAL10791.1; JOINED; Genomic_DNA.
DR   EMBL; AF349017; AAL05624.1; -; mRNA.
DR   EMBL; AK316380; BAH14751.1; -; mRNA.
DR   EMBL; AC087793; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC044646; AAH44646.1; ALT_INIT; mRNA.
DR   EMBL; BC052285; AAH52285.1; -; mRNA.
DR   EMBL; BC071914; AAH71914.1; -; mRNA.
DR   CCDS; CCDS59115.1; -. [Q969P6-2]
DR   CCDS; CCDS6400.1; -. [Q969P6-1]
DR   RefSeq; NP_001245375.1; NM_001258446.1. [Q969P6-2]
DR   RefSeq; NP_001245376.1; NM_001258447.1. [Q969P6-2]
DR   RefSeq; NP_443195.1; NM_052963.2. [Q969P6-1]
DR   AlphaFoldDB; Q969P6; -.
DR   SMR; Q969P6; -.
DR   BioGRID; 125510; 36.
DR   IntAct; Q969P6; 11.
DR   STRING; 9606.ENSP00000328835; -.
DR   ChEMBL; CHEMBL2362989; -.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB01030; Topotecan.
DR   DrugCentral; Q969P6; -.
DR   GlyGen; Q969P6; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q969P6; -.
DR   PhosphoSitePlus; Q969P6; -.
DR   SwissPalm; Q969P6; -.
DR   BioMuta; TOP1MT; -.
DR   DMDM; 20140694; -.
DR   EPD; Q969P6; -.
DR   jPOST; Q969P6; -.
DR   MassIVE; Q969P6; -.
DR   MaxQB; Q969P6; -.
DR   PaxDb; Q969P6; -.
DR   PeptideAtlas; Q969P6; -.
DR   ProteomicsDB; 17936; -.
DR   ProteomicsDB; 75812; -. [Q969P6-1]
DR   Antibodypedia; 958; 287 antibodies from 27 providers.
DR   CPTC; Q969P6; 3 antibodies.
DR   DNASU; 116447; -.
DR   Ensembl; ENST00000329245.9; ENSP00000328835.3; ENSG00000184428.13. [Q969P6-1]
DR   Ensembl; ENST00000519148.5; ENSP00000429169.1; ENSG00000184428.13. [Q969P6-2]
DR   Ensembl; ENST00000521193.5; ENSP00000428369.1; ENSG00000184428.13. [Q969P6-2]
DR   Ensembl; ENST00000523676.5; ENSP00000429181.1; ENSG00000184428.13. [Q969P6-2]
DR   GeneID; 116447; -.
DR   KEGG; hsa:116447; -.
DR   MANE-Select; ENST00000329245.9; ENSP00000328835.3; NM_052963.3; NP_443195.1.
DR   UCSC; uc003yxz.6; human. [Q969P6-1]
DR   AGR; HGNC:29787; -.
DR   CTD; 116447; -.
DR   DisGeNET; 116447; -.
DR   GeneCards; TOP1MT; -.
DR   HGNC; HGNC:29787; TOP1MT.
DR   HPA; ENSG00000184428; Low tissue specificity.
DR   MIM; 606387; gene.
DR   neXtProt; NX_Q969P6; -.
DR   OpenTargets; ENSG00000184428; -.
DR   PharmGKB; PA134922772; -.
DR   VEuPathDB; HostDB:ENSG00000184428; -.
DR   eggNOG; KOG0981; Eukaryota.
DR   GeneTree; ENSGT00940000162943; -.
DR   HOGENOM; CLU_009193_2_0_1; -.
DR   InParanoid; Q969P6; -.
DR   OMA; NWWEQEN; -.
DR   OrthoDB; 10940at2759; -.
DR   PhylomeDB; Q969P6; -.
DR   TreeFam; TF105281; -.
DR   BRENDA; 5.6.2.1; 2681.
DR   PathwayCommons; Q969P6; -.
DR   SignaLink; Q969P6; -.
DR   SIGNOR; Q969P6; -.
DR   BioGRID-ORCS; 116447; 63 hits in 1164 CRISPR screens.
DR   ChiTaRS; TOP1MT; human.
DR   GenomeRNAi; 116447; -.
DR   Pharos; Q969P6; Tclin.
DR   PRO; PR:Q969P6; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q969P6; protein.
DR   Bgee; ENSG00000184428; Expressed in right lobe of liver and 137 other tissues.
DR   ExpressionAtlas; Q969P6; baseline and differential.
DR   Genevisible; Q969P6; HS.
DR   GO; GO:0005694; C:chromosome; IEA:InterPro.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003917; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; IBA:GO_Central.
DR   GO; GO:0006260; P:DNA replication; IBA:GO_Central.
DR   GO; GO:0006265; P:DNA topological change; IBA:GO_Central.
DR   CDD; cd00659; Topo_IB_C; 1.
DR   CDD; cd03488; Topoisomer_IB_N_htopoI_like; 1.
DR   Gene3D; 1.10.132.10; -; 1.
DR   Gene3D; 2.170.11.10; DNA Topoisomerase I, domain 2; 1.
DR   Gene3D; 1.10.10.41; Yeast DNA topoisomerase - domain 1; 1.
DR   InterPro; IPR011010; DNA_brk_join_enz.
DR   InterPro; IPR013034; DNA_topo_DNA_db_N_dom1.
DR   InterPro; IPR013030; DNA_topo_DNA_db_N_dom2.
DR   InterPro; IPR001631; TopoI.
DR   InterPro; IPR018521; TopoI_AS.
DR   InterPro; IPR025834; TopoI_C_dom.
DR   InterPro; IPR014711; TopoI_cat_a-hlx-sub_euk.
DR   InterPro; IPR014727; TopoI_cat_a/b-sub_euk.
DR   InterPro; IPR013500; TopoI_cat_euk.
DR   InterPro; IPR008336; TopoI_DNA-bd_euk.
DR   InterPro; IPR036202; TopoI_DNA-bd_euk_N_sf.
DR   InterPro; IPR013499; TopoI_euk.
DR   PANTHER; PTHR10290; DNA TOPOISOMERASE I; 1.
DR   PANTHER; PTHR10290:SF1; DNA TOPOISOMERASE I, MITOCHONDRIAL; 1.
DR   Pfam; PF14370; Topo_C_assoc; 1.
DR   Pfam; PF01028; Topoisom_I; 1.
DR   Pfam; PF02919; Topoisom_I_N; 1.
DR   PRINTS; PR00416; EUTPISMRASEI.
DR   SMART; SM00435; TOPEUc; 1.
DR   SUPFAM; SSF56349; DNA breaking-rejoining enzymes; 1.
DR   SUPFAM; SSF46596; Eukaryotic DNA topoisomerase I, dispensable insert domain; 1.
DR   SUPFAM; SSF56741; Eukaryotic DNA topoisomerase I, N-terminal DNA-binding fragment; 1.
DR   PROSITE; PS00176; TOPOISOMERASE_I_EUK; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Isomerase; Mitochondrion;
KW   Reference proteome; Topoisomerase; Transit peptide.
FT   TRANSIT         1..50
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000305|PubMed:11526219"
FT   CHAIN           51..601
FT                   /note="DNA topoisomerase I, mitochondrial"
FT                   /id="PRO_0000034797"
FT   REGION          22..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          261..262
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          324..329
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          421..423
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        559
FT                   /note="O-(3'-phospho-DNA)-tyrosine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10130"
FT   SITE            152
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            200
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            248
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            279
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            337
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            368
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            410
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            468
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            486
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..98
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044783"
FT   VARIANT         256
FT                   /note="V -> I (in dbSNP:rs11544484)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_052593"
FT   VARIANT         525
FT                   /note="R -> W (in dbSNP:rs2293925)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_021863"
FT   CONFLICT        116
FT                   /note="N -> S (in Ref. 2; BAH14751)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   601 AA;  69872 MW;  A012248D4250C675 CRC64;
     MRVVRLLRLR AALTLLGEVP RRPASRGVPG SRRTQKGSGA RWEKEKHEDG VKWRQLEHKG
     PYFAPPYEPL PDGVRFFYEG RPVRLSVAAE EVATFYGRML DHEYTTKEVF RKNFFNDWRK
     EMAVEEREVI KSLDKCDFTE IHRYFVDKAA ARKVLSREEK QKLKEEAEKL QQEFGYCILD
     GHQEKIGNFK IEPPGLFRGR GDHPKMGMLK RRITPEDVVI NCSRDSKIPE PPAGHQWKEV
     RSDNTVTWLA AWTESVQNSI KYIMLNPCSK LKGETAWQKF ETARRLRGFV DEIRSQYRAD
     WKSREMKTRQ RAVALYFIDK LALRAGNEKE DGEAADTVGC CSLRVEHVQL HPEADGCQHV
     VEFDFLGKDC IRYYNRVPVE KPVYKNLQLF MENKDPRDDL FDRLTTTSLN KHLQELMDGL
     TAKVFRTYNA SITLQEQLRA LTRAEDSIAA KILSYNRANR VVAILCNHQR ATPSTFEKSM
     QNLQTKIQAK KEQVAEARAE LRRARAEHKA QGDGKSRSVL EKKRRLLEKL QEQLAQLSVQ
     ATDKEENKQV ALGTSKLNYL DPRISIAWCK RFRVPVEKIY SKTQRERFAW ALAMAGEDFE
     F
//
